The intersection of lipid metabolism and inflammation in the setting of cardiovascular disease is the overall theme of our PPG. In the revised application we emphasize three specific areas within this major theme that serve as nodal points for the interactions of the component projects; i) Intestine; ii) Lipid Metabolism & Dyslipidemia; and iii) Vascular inflammation. Projects 1, 4 an 5 directly propose specific aims related to the intestine. Projects 1, 2, 4 and 5 propose specific aims related to diet-induced changes in lipid metabolism that result in dyslipidemia, or are directly affected by dyslipidemia. Additionally, Project 3 proposes specific aims related to lipid metabolism in adipose tissue. All five projects propose specific aims related to vascular inflammation. Project 1 (Fogelman) proposes two specific aims.
Aim 1 will determine the mechanisms by which unsaturated lysophosphatidic acid (LPA) and a Western diet (WD) act in the small intestine to cause dyslipidemia and inflammation.
Aim 2 will determine the mechanisms by which transgenic tomatoes expressing an apoA-I mimetic peptide (6F) ameliorates dyslipidemia and inflammation caused by intestinally-derived LPA or WD. Project 2 (Iruela-Arispe) proposes three specific aims.
Aim1 is to identify the mechanism by which pro-atherogenic lipids regulate NOTCH1.
Aim 2 is to determine the role of NOTCH1 in the regulation of barrier stability.
Aim 3 will ascertain the contribution of Notch1 to atherosclerosis using animl models. Project 3 (Bostrom) proposes two specific aims.
Aim 1 will test the hypothesis that the balance between BMP activity and inhibition regulates angiogenesis and adipogenesis in adipose tissue.
Aim 2 will investigate the impact of diabetes, lipid delivery and genetic variation on the balance between BMP activity and inhibition, and adipogenesis and angiogenesis in adipose tissue. Project 4 (Lusis/Edwards) proposes two specific aims.
Aim 1 will use the systems genetics data collected during the present cycle to model interactions in inflammation and atherosclerosis, including the involvement of Notch1, intestinal LPA and Lpcat3.
Aim 2 will test the hypothesis that the transcription factor Zhx2 is required for the survival and proliferatin of macrophage and foam cells in atherosclerotic lesions. Project 5 (Tontonoz) proposes three specific aims.
Aim 1 is to elucidate the role of Lpcat3-dependent phospholipid remodeling in lipid metabolism.
Aim 2 is to determine the role of the LXR-Lpcat3 pathway in inflammation.
Aim 3 is to determine the role of the LXR-Lpcat3 pathway in atherogenesis. Two cores will provide support to the component projects. Core A will provide administrative services. Core B will provide scientific services; analytical chemistry assays, molecular biology related services and morphology related services. The synergy between these specific aims with the support of the cores will result in a novel and comprehensive approach to understanding the intersection of lipid metabolism and inflammation. (End of Abstract) INDIVIDUAL PROJECTS AND CORE UNITS PROJECT 1:FOGELMAN PROJECT: A NOVEL ROLE OF THE SMALL INTESTINE IN DYSLIPIDEMIA AND VASCULAR INFLAMMATION (Fogelman, Alan M.)

Public Health Relevance

Cardiovascular disease remains a major health problem. This Program Project proposes novel approaches to understand fundamental mechanisms that connect the intestine, lipid metabolism and dyslipidemia to vascular inflammation, which leads to heart attack and stroke. Based on the fundamental mechanisms involved this Program also proposes novel approaches to the prevention and treatment of cardiovascular disease.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-PPG-N (M1))
Program Officer
Liu, Lijuan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Los Angeles
Internal Medicine/Medicine
Schools of Medicine
Los Angeles
United States
Zip Code
Norheim, Frode; Bjellaas, Thomas; Hui, Simon T et al. (2018) Genetic, dietary, and sex-specific regulation of hepatic ceramides and the relationship between hepatic ceramides and IR. J Lipid Res 59:1164-1174
Yu, Jingyi; Seldin, Marcus M; Fu, Kai et al. (2018) Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity. Circ Res 123:73-85
Jumabay, Medet; Zhumabai, Jiayinaguli; Mansurov, Nurlan et al. (2018) Combined effects of bone morphogenetic protein 10 and crossveinless-2 on cardiomyocyte differentiation in mouse adipocyte-derived stem cells. J Cell Physiol 233:1812-1822
Mangul, Serghei; Yang, Harry Taegyun; Strauli, Nicolas et al. (2018) ROP: dumpster diving in RNA-sequencing to find the source of 1 trillion reads across diverse adult human tissues. Genome Biol 19:36
Mack, Julia J; Iruela-Arispe, M Luisa (2018) NOTCH regulation of the endothelial cell phenotype. Curr Opin Hematol 25:212-218
Beceiro, Susana; Pap, Attila; Czimmerer, Zsolt et al. (2018) LXR nuclear receptors are transcriptional regulators of dendritic cell chemotaxis. Mol Cell Biol :
Sallam, Tamer; Jones, Marius; Thomas, Brandon J et al. (2018) Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA. Nat Med 24:304-312
Skye, Sarah M; Zhu, Weifei; Romano, Kymberleigh A et al. (2018) Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential. Circ Res 123:1164-1176
Lin, Liang-Yu; Chun Chang, Sunny; O'Hearn, Jim et al. (2018) Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans. G3 (Bethesda) 8:3499-3506
Rahmani, Elior; Schweiger, Regev; Shenhav, Liat et al. (2018) BayesCCE: a Bayesian framework for estimating cell-type composition from DNA methylation without the need for methylation reference. Genome Biol 19:141

Showing the most recent 10 out of 791 publications